Clinical Trials · NCT01076335
Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancer
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- M.D. Anderson Cancer Center
- Enrollment
- 40
- Start date
- May 2005
- Locations
- 1 site, United States
- Primary endpoint
- Number of Participants Progression Free at 1 Year